Related Experiment Videos
Preclinical evaluation of submillimeter diameter microwave interstitial hyperthermia applicators
C Gottlieb1, F Moffat, M Hagmann
1Department of Radiation Oncology, University of Miami School of Medicine, FL 33101.
Summary
New ultra-miniature hyperthermia applicators, smaller than commercial devices, show reduced tissue trauma in animal studies. These 0.20-0.58 mm applicators are suitable for treating deep tumors via minimally invasive techniques.
Area of Science:
- Biomedical Engineering
- Medical Physics
- Oncology
Background:
- Interstitial hyperthermia is a cancer treatment modality.
- Current hyperthermia applicators have limitations in size and invasiveness.
- Minimally invasive techniques are crucial for treating deep-seated tumors.
Purpose of the Study:
- To develop and evaluate ultra-miniature interstitial hyperthermia applicators.
- To assess the efficacy and safety of novel small-diameter applicators.
- To determine the potential of these applicators for clinical use in cancer treatment.
Main Methods:
- Fabrication of ultra-miniature applicators (0.20-0.58 mm diameter) using microscopic techniques and coaxial cable.
- Measurement of heating patterns (Specific Absorption Rate - SAR) in tissue-simulating phantoms using a miniature electric field probe.
- Evaluation of applicator performance in perfused animal tissue models (pig thigh and liver).
Main Results:
- Ultra-miniature applicators produced less local tissue trauma compared to larger commercial devices in animal studies.
- Applicators demonstrated adequate durability and power handling for patient use.
- Heating patterns were consistent across different applicator sizes due to scaled design and monopole operation at 915 MHz.
Conclusions:
- Ultra-miniature hyperthermia applicators offer a promising alternative to larger devices, with reduced tissue trauma.
- These applicators are suitable for percutaneous, intraoperative, intraluminal, and intravascular tumor treatments.
- Further clinical trials are warranted to validate the efficacy of these novel applicators.